The paradigm of possibilities leading to the formation of autoimmune and infectious phenotypes of common variable immune deficiency
- Authors: Sizyakina L.P.1, Andreeva I.I.1, Danilova D.I.1
-
Affiliations:
- Rostov State Medical University
- Issue: Vol 27, No 4 (2024)
- Pages: 1009-1016
- Section: SHORT COMMUNICATIONS
- URL: https://ogarev-online.ru/1028-7221/article/view/267920
- DOI: https://doi.org/10.46235/1028-7221-16690-TPO
- ID: 267920
Cite item
Full Text
Abstract
The term variable in the definition of CVID is associated with the heterogeneity of the genetic nature and clinical manifestation of this variant of PI. Deciphering of the mechanisms or identifying biomarkers of clinical heterogeneity may be important in the timely diagnosis and prognosis of the course of CVID. The purpose of the study was to identify distinctive features in the parameters of the innate and adaptive immune response of the patients with infectious and autoimmune manifestations of CVID in remission and clinical manifestation. Fifteen patients, 11 women and 4 men with an average age 39.7±11.7 years were examined, and they were divided into two subgroups depending on clinical verification: infectious phenotype (10 people) and autoimmune phenotype (5 people). In the absence of clinical signs of activation of autoimmune pathology or exacerbation of chronic infectious processes, peripheral blood monocytes became the application point of distinctive values. An increase in the number of TLR9-expressing monocytes has been shown in patients with autoimmune clinical verification of CVID. The differences in the parameters of the immune status of patients conducted during the period of clinical manifestation consisted of a decrease in the relative content and absolute number of T regulatory lymphocytes, and an increase in the number of monocytes containing TLR9, TLR2 and HLA-DR in patients with an autoimmune phenotype relative to the subgroup with infectious manifestation. The data obtained reflect the involvement of the immunoregulatory potential of the immune system in the clinical manifestation of primary immunodeficiency, even under the conditions of pathogenetic substitution therapy. The evidence of the stated position is a decrease in immunosuppression in autoimmune manifestation due to a decrease in the number of peripheral T-regulatory cells and a smaller proportion of monocyte cells belonging to the M2 suppressive category. Attention is also drawn to the increased potential of primary response to patterns of various nature in autoimmune manifestation due to an increase in the number of monocytes expressing Toll-like receptors of various specificity. The presented results can be proposed as a diagnostic and prognostic indicator of the difference in clinical phenotypes of CVID.
Full Text
##article.viewOnOriginalSite##About the authors
L. P. Sizyakina
Rostov State Medical University
Email: iai3012@rambler.ru
PhD, MD (Medicine), Professor, Head, Department of Clinical Immunology and Allergology, Director, Research Institute of Clinical Immunology
Russian Federation, 29 Nakhichevan Lane, Rostov-on-Don, 344022I. I. Andreeva
Rostov State Medical University
Author for correspondence.
Email: iai3012@rambler.ru
PhD, MD (Medicine), Professor, Department of Clinical Immunology and Allergology
Russian Federation, 29 Nakhichevan Lane, Rostov-on-Don, 344022D. I. Danilova
Rostov State Medical University
Email: iai3012@rambler.ru
PhD (Medicine), Assistant Professor, Department of Personalized and Translational Medicine
Russian Federation, 29 Nakhichevan Lane, Rostov-on-Don, 344022References
- Сизякина Л.П., Андреева И.И., Харитонова М.В. В-2 лимфоциты и баланс про и противовоспалительных цитокинов при инфекционном и аутоиммунном фенотипах общей вариабельной иммунной недостаточности // Медицинский вестник Юга России, 2023. Т. 14, № 4. С. 17-21. [Sizyakina L.P., Andreeva I.I., Kharitonova M.V. B-2 lymphocytes and the balance of pro and anti-inflammatory cytokines in infectious and autoimmune phenotypes of common variable immune deficiency. Meditsinskiy vestnik Yuga Rossii = Medical Bulletin of the South of Russia, 2023, Vol. 14, no. 4, pp. 17-21. (In Russ.)]
- Agarwal S., Cunningham-Rundles C. Autoimmunity in common variable immunodeficiency. Ann. Allergy Asthma Immunol., 2019, Vol. 123, no. 5, pp. 454-460.
- Bonilla F.A., Barlan I., Chapel H., Costa-Carvalho B.T., Cunningham-Rundles C., de la Morena M.T., Espinosa-Rosales F.J., Hammarström L., Nonoyama S., Quinti I., Routes J.M., Tang M.L.K., Warnatz K. International Consensus Document (ICON): Common Variable Immunodeficiency Disorders. J. Allergy Clin. Immunol. Pract., 2016, Vol. 4, no. 1, pp. 38-59.
- Filion C.A., Taylor-Black S., Maglione P.J., Radigan L., Cunningham-Rundles C. Differentiation of Common Variable Immunodeficiency From IgG Deficiency. J. Allergy Clin. Immunol. Pract., 2019, Vol. 7, no. 4, pp. 1277-1284.
- Galicia G., Gommerman J.L. Plasmacytoid dendritic cells and autoimmune inflammation. Biol. Chem., 2014, Vol. 395, no. 3, pp. 335-346.
- Ghafoor A., Joseph S.M. Making a Diagnosis of Common Variable Immunodeficiency: A Review. Cureus, 2020, Vol.12, no. 1, e6711. doi: 10.7759/cureus.6711.
- Haymore B.R., Mikita C.P., Tsokos G.C. Common variable immune deficiency (CVID) presenting as an autoimmune disease: role of memory B cells. Autoimmun. Rev., 2008, Vol. 7, no. 4, pp. 309-312.
- Leonardi L., Lorenzetti G., Carsetti R., Ferrari S., di Felice A., Cinicola B., Duse M. Rare TACI mutation in a 3-year-old boy with CVID phenotype. Front. Pediatr., 2019, no. 7, 418. doi: 10.3389/fped.2019.00418.
- López-Herrera G., Segura-Méndez N.H., O’Farril-Romanillos P., Nuñez-Nuñez M.E., Zarate-Hernández M.C., Mogica-Martínez D., Yamazaki-Nakashimada M.A., Staines-Boone A.T., Santos-Argumedo L., Berrón-Ruiz L. Low percentages of regulatory T cells in common variable immunodeficiency (CVID) patients with autoimmune diseases and its association with increased numbers of CD4+CD45RO+ T and CD21low B cells. Allergol. Immunopathol., 2019, Vol. 47, no. 5, pp. 457-466.
- Mormile I., Punziano A., Riolo C.A., Granata F., Williams M., de Paulis A., Spadaro G., Rossi F.W. Common variable immunodeficiency and autoimmune diseases: a retrospective study of 95 adult patients in a single tertiary care center. Front. Immunol., 2021, no. 12, 652487. doi: 10.3389/fimmu.2021.652487.
- Nepesov S., Aygun F.D., Firtina S., Cokugras H., Camcioglu Y. Clinical and immunological features of 44 common variable immunodeficiency patients: the experience of a single center in Turkey. Allergol. Immunopathol., 2020, Vol. 48, no. 6, pp. 675-685.
- Remiker A., Bolling K., Verbsky J. Common variable immunodeficiency. Med. Clin. North. Am., 2024, Vol. 108, no. 1, pp. 107-121.
- Rutkowska-Zapała M., Grabowska-Gurgul A., Lenart M., Szaflarska A., Kluczewska A., Mach-Tomalska M., Baj-Krzyworzeka M., Siedlar M. Gene signature of regulatory T cells isolated from children with selective IgA deficiency and common variable immunodeficiency. Cells, 2024, Vol. 3, no. 5, 417. doi: 10.3390/cells13050417.
- Saber M.M., Monir N., Awad A.S., Elsherbiny M.E., Zaki H.F. TLR9: A friend or a foe. Life Sci., 2022, no. 307, 120874. doi: 10.1016/j.lfs.2022.120874.
- Tangye, S.G., Al-Herz, W., Bousfiha A., Cunningham-Rundles C., Franco J.L., Holland S.M., Klein C., Morio T., Oksenhendler E., Picard C., Puel A., Puck J., Seppänen M.R.J., Somech R., Su H.C., Sullivan K.E., Torgerson T.R., Meyts I. Human inborn errors of immunity: 2022 update on the classification from the international union of immunological societies expert committee. J. Clin. Immunol., 2022, no. 42, pp. 1473-1507.
Supplementary files
